- Home
- CAKE vs ZLAB Comparison
CAKE vs ZLAB Comparison
Compare CAKE & ZLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CAKE
- ZLAB
- Stock Information
- Founded
- CAKE 1972
- ZLAB 2013
- Country
- CAKE United States
- ZLAB China
- Employees
- CAKE N/A
- ZLAB N/A
- Industry
- CAKE Restaurants
- ZLAB Biotechnology: Pharmaceutical Preparations
- Sector
- CAKE Consumer Discretionary
- ZLAB Health Care
- Exchange
- CAKE Nasdaq
- ZLAB Nasdaq
- Market Cap
- CAKE 2.0B
- ZLAB 1.8B
- IPO Year
- CAKE 1992
- ZLAB 2017
- Fundamental
- Price
- CAKE $47.79
- ZLAB $31.24
- Analyst Decision
- CAKE Hold
- ZLAB Strong Buy
- Analyst Count
- CAKE 14
- ZLAB 4
- Target Price
- CAKE $41.38
- ZLAB $52.50
- AVG Volume (30 Days)
- CAKE 1.1M
- ZLAB 976.3K
- Earning Date
- CAKE 10-29-2024
- ZLAB 11-12-2024
- Dividend Yield
- CAKE 2.52%
- ZLAB N/A
- EPS Growth
- CAKE 82.87
- ZLAB N/A
- EPS
- CAKE 2.39
- ZLAB N/A
- Revenue
- CAKE $3,502,484,000.00
- ZLAB $322,711,000.00
- Revenue This Year
- CAKE $6.24
- ZLAB $48.34
- Revenue Next Year
- CAKE $5.72
- ZLAB $47.12
- P/E Ratio
- CAKE $17.90
- ZLAB N/A
- Revenue Growth
- CAKE 2.74
- ZLAB 28.16
- 52 Week Low
- CAKE $29.27
- ZLAB $13.48
- 52 Week High
- CAKE $43.73
- ZLAB $36.60
- Technical
- Relative Strength Index (RSI)
- CAKE 77.12
- ZLAB 70.41
- Support Level
- CAKE $40.72
- ZLAB $31.52
- Resistance Level
- CAKE $43.51
- ZLAB $36.60
- Average True Range (ATR)
- CAKE 1.28
- ZLAB 1.36
- MACD
- CAKE 0.52
- ZLAB 0.34
- Stochastic Oscillator
- CAKE 99.28
- ZLAB 58.60
About CAKE Cheesecake Factory Incorporated (The)
Cheesecake Factory Inc owns and operates restaurants in the United States and Canada under brands that include The Cheesecake Factory, North Italia, and a collection within the Fox Restaurants Concepts subsidiary. The company's international presence, in the Middle East and Mexico, is through licensing agreements with third parties. The company also has a bakery division that produces cheesecakes and other baked products for sale in its restaurants, international licensees, and third-party bakery customers. The company has four operating business segments: The Cheesecake Factory restaurants, North Italia, other FRC, and Flower Child. Majority of the company's revenue comes from The Cheesecake Factory restaurants segment.
About ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-2306 for treatments across multiple solid tumor types including ovarian and certain types of breast and lung cancers; ZL-2401 which is an antibiotic in a new class of tetracycline derivatives; and ZL-2301 is an oral, small molecule which targets HCC.